JobGrades

• SF Bay Area
• San Diego
• New York City
• More Cities
  • Atlanta
  • Austin
  • Boston
  • Chicago
  • Denver
  • Houston
  • Los Angeles
  • New York City
  • Orange County
  • Philadelphia
  • Phoenix
  • Portland
  • San Diego
  • Seattle
  • SF Bay Area
  • Toronto, Canada
  • Vancouver, Canada
  • Washington DC

• Computer Software
• Computer Hardware
• Engineering
• Internet
• Finances/Investments
• All Categories

• Accounting
• Advertising
• Aerospace
• Automotive
• Biotechnology
• Computer Hardware
• Computer Software
• Defense
• Education
• Engineering
• Finances/Investments
• Government
• Healthcare
• Information Technology
• Insurance
• Internet
• Law Firms/Legal services
• Marketing
• Media
• Nonprofit
• Pharmaceutical
• Public Relations
• Real Estate
• Research
• Restaurant
• Retail/Consumer Products
• Sales
• Sports and Recreation
• TV/Film/Video

Amgen Blog News

• Earful for Amgen's CEO 32 mins ago
Details from the Amgen shareholder meeting, with CNBC's Mike Huckman.
• Amgen's Visit From The "Tooth Fairy" (By Way Of Root Canal?)
There's no money left under the pillow, but Amgen execs and directors have been handed a gift. One of the most outspoken, large, individual investors in the biotech company who's been calling for the Board and CEO to go won't be ...
• Amgen Inc. (up 0.49 percent, AMGN) is showing sign of recovery?
Up 0.49% today. The stock has recovered 9.8% from its recent low price of 39.16 which occurred on 20-Mar-2008. The current price is above the 20 day moving average of 42.69. The stock could possibly find resistance at the 50 day moving ...
• Amgen to Participate in Meeting in May
(BUSINESS WIRE)-- Amgen (NASDAQ:AMGN) today announced that the European Committee for Medicinal Products for Human Use (CHMP) has requested Amgen and other erythropoiesis-stimulating agent (ESA) marketing authorization holders to ...
• Amgen to Participate in CHMP Oncology Scientific Advisory Group ...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Amgen (NASDAQ:AMGN) today announced that the European Committee for Medicinal Products for Human Use (CHMP) has requested Amgen and other.
• Is the short recovery in Amgen Inc. (down 0.33 percent, AMGN) for ...
Down -0.33% today. The stock has recovered 9.3% from its recent low price of 39.16 which occurred on 20-Mar-2008. The current price is above the 20 day moving average of 42.62. The stock could possibly find resistance at the 50 day ...
• Is the short recovery in Amgen Inc. (down 0.69 percent, AMGN) for ...
Down -0.69% today. The stock has recovered 9.6% from its recent low price of 39.16 which occurred on 20-Mar-2008. The current price is above the 20 day moving average of 42.55. The stock could possibly find resistance at the 50 day ...
• Wyeth and Amgen bolster fatal infection warning on skin drug
Drugmakers Wyeth and Amgen Inc. have bolstered warnings about tuberculosis and other life-threatening infections on the label of their skin-disorder drug Enbrel. The new boxed warning, the most serious a drug can carry, ...
• A Message From Your Friends At Amgen
If you want to play in the big leagues you have to have talent. Bye bye you pathetic bunch of losers. Amgen is in it for the long haul, OBI will not exist in 6 months. Amgen is an industry leader, JNJ yesterdays news.
• We hired who from Amgen ?
Thanks Allergan for taking the defective units out of Amgen , we are so pleased that you were willing to compensate these useless units that we have been trying to get rid of. We appreciate that you have taken the time and $$ to take ...